Abstract
Technetium-99m sestamibi (Tc-99m MIBI) is a routinely used radiopharmaceutical for myocardial perfusion scintigraphy (MPS). Here, we present a case of a 76-year-old woman with mild transient chest pain but normal laboratory examination results who underwent Tc-99m sestamibi (MIBI) myocardial perfusion imaging, and an abnormal focal radionuclide uptake in the left lobe of the thyroid gland was detected. After that, the patient underwent left hemithyroidectomy, and the result of the pathology came out as follicular adenoma. In this case, we wanted to discuss the significance of MIBI uptake in thyroid nodules and discuss the importance of evaluating raw data images for the detection of noncardiac pathologies in myocardial perfusion scintigraphy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
